The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

7 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis, biological evaluation and molecular docking studies of 2-piperazin-1-yl-quinazolines as platelet aggregation inhibitors and ligands of integrinaIIbß3.EBI
A.V. Bogatsky Physico-Chemical Institute of The National Academy of Sciences of Ukraine
Design, Virtual Screening, and Synthesis of Antagonists ofaIIbß3 as Antiplatelet Agents.EBI
A.V. Bogatsky Physico-Chemical Institute of The National Academy of Sciences of Ukraine
Synthesis, biological evaluation, X-ray molecular structure and molecular docking studies of RGD mimetics containing 6-amino-2,3-dihydroisoindolin-1-one fragment as ligands of integrinaIIbß3.EBI
A.V. Bogatsky Physico-Chemical Institute of The National Academy of Sciences of Ukraine
Derivatives of 7-amino-1,2,3,4-tetrahydroisoquinoline and isophthalic acids as novel fibrinogen receptor antagonists.EBI
A.V. Bogatsky Physico-Chemical Institute of The National Academy of Sciences of Ukraine
Novel fibrinogen receptor antagonists. RGDF mimetics, derivatives of 4-(isoindoline-5-yl)amino-4-oxobutyric acid.EBI
A.V. Bogatsky Physico-Chemical Institute of The National Academy of Sciences of Ukraine
RGD mimetics containing phthalimidine fragment as novel ligands of fibrinogen receptor.EBI
A.V. Bogatsky Physico-Chemical Institute of The National Academy of Sciences of Ukraine
Derivatives of tetrahydroisoquinoline: synthesis and initial evaluation of novel non-peptide antagonists of the alpha(IIb)beta(3)-integrin.EBI
A.V. Bogatsky Physico-Chemical Institute of The National Academy of Sciences of Ukraine